| 2 | 聚焦超声手术治疗子宫肌瘤的临床效果显示文摘Objective: To assess outcomes at 6 and 12 months after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for symptomatic uterine leiomyomas. Design: Multicenter clinical trial. Setting: Academic medical centers. Patient(s): Premenopausal women with symptomatic uterine leiomyomas and no plans for future pregnancy (n = 109 at 6 months and n = 82 at 12 months). Intervention(s): A single treatment session of MRgFUS for uterine fibroids. Main Outcome Measure(s): Reduction in fibroid symptoms as measured by the symptom severity score (SSS) of the Uterine Fibroid Quality-of-Life Instrument (UFS-QOL), the only validated measure of leiomyoma symptomatology. A 10-point reduction in the SSS was selected as the targeted improvement. Result(s): Seventy-one percent of women undergoing MRgFUS reached the targeted symptom reduction at 6 months, and 51%reached this at 12 months. The magnitude of improvement in SSS was greater than predicted, with subjects having a mean decrease of 39%and 36%at 6 and 12 months, respectively. This paralleled the improvement seen using the short form-36 instrument. A modest volume reduction similar in magnitude to the treated volume was seen. The incidence of adverse events was low. Conclusion(s): MRgFUS treatment results in short-term symptom reduction for women with symptomatic uterine leiomyomas with an excellent safety profile. | Stewart E.A. Rabinovici J. Tempany C.M.C. 李跃萍 | 2006 | 世界核心医学期刊文摘(妇产科学分册)2006，0，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员